Loading...
Docoh

Societal CDMO (SCTL)

News

From Benzinga Pro
Stocks That Hit 52-Week Lows On Wednesday
25 May 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
On Wednesday, 215 companies set new 52-week lows.
90 Biggest Movers From Yesterday
13 May 22
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) surged 70.5% to close at $0.1330 on Thursday after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered direct offering.
Recap: Societal CDMO Q1 Earnings
11 May 22
Earnings
Societal CDMO (NASDAQ:SCTL) reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Societal CDMO beat estimated earnings by 11.11%, reporting an EPS of $-0.08 versus an estimate of $-0.09.
Earnings Scheduled For May 11, 2022
11 May 22
Earnings, News, Pre-Market Outlook, Markets
Companies Reporting Before The Bell • Great Elm Capital (NASDAQ:GECC) is expected to report earnings for its first quarter.
Earnings Outlook For Societal CDMO
10 May 22
Earnings
Societal CDMO (NASDAQ:SCTL) is set to give its latest quarterly earnings report on Wednesday, 2022-05-11. Here's what investors need to know before the announcement. Analysts estimate that Societal CDMO will report an earnings per share (EPS) of $-0.09.
Executives Buy Around $5M Of 3 Penny Stocks
21 Apr 22
Long Ideas, News, Penny Stocks, Insider Trades, Markets, Trading Ideas
US stocks closed mixed on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Recro Pharma Earnings Perspective: Return On Capital Employed
7 Mar 22
Earnings
According to data from Benzinga Pro, during Q4, Recro Pharma's (NASDAQ:REPH) reported sales totaled $22.30 million. Despite a 32.39% increase in earnings, the company posted a loss of $2.36 million.
Recap: Recro Pharma Q4 Earnings
1 Mar 22
Earnings
Recro Pharma (NASDAQ:REPH) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Recro Pharma Q4 EPS $(0.04) Beats $(0.07) Estimate, Sales $22.30M Beat $21.41M Estimate
1 Mar 22
Earnings, News
Recro Pharma (NASDAQ:REPH) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.07) by 42.86 percent. This is a 91.67 percent increase over losses of $(0.48) per share from the
Earnings Scheduled For March 1, 2022
1 Mar 22
Earnings, News, Pre-Market Outlook, Markets
Companies Reporting Before The Bell • Precigen (NASDAQ:PGEN) is expected to report earnings for its fourth quarter.

Press releases

From Benzinga Pro
Societal CDMO Reports First Quarter 2022 Financial Results
11 May 22
Earnings, Press Releases
Recorded Q1 Revenue of $21 Million; A 26% Increase Compared to Prior Year Period Signed Multiple New Business Agreements Spanning Early Stage Through Commercial Manufacturing Launching Aseptic Fill-Finish and
Societal CDMO to Report Financial Results for First Quarter 2022 on May 11, 2022
4 May 22
News, Press Releases
SAN DIEGO and GAINESVILLE, Ga., May 04, 2022 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. ("Societal CDMO" or "Societal"; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving
Societal CDMO Secures Manufacturing and Packaging Task Order Award from National Cancer Institute (NCI)
27 Apr 22
Press Releases
SAN DIEGO and GAINESVILLE, Ga., April 27, 2022 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. ("Societal CDMO"; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex
Societal CDMO Reports Inducement Grants for New Staff
6 Apr 22
Press Releases
SAN DIEGO and GAINESVILLE, Ga., April 06, 2022 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. ("Societal CDMO"; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex
Recro Announces Name Change to Societal CDMO to Reflect Corporate Expansion and Transformation
21 Mar 22
News, Press Releases
With Expanded Industry Expertise, Enhanced Service Offerings and Bi-Coastal Operations, Company Now Optimally Positioned to Support Customers' Goal of Delivering Impactful Medicines to Society New Ticker (NASDAQ:SCTL)
Recro Reports Fourth Quarter and Year End 2021 Financial Results
1 Mar 22
Earnings, Press Releases
Recorded Q4 Revenue of $22.3 Million; Full Year Revenue of $75.4 Million More than Tripled Customer Base in 2021; Significantly Diversified Clientele Grew Organic New Business by 63% in 2021; Grew by 147% Including